Literature DB >> 9730862

Antibacterial peptides in bronchoalveolar lavage fluid.

D Schnapp1, A Harris.   

Abstract

Defensins and other antimicrobial peptides act in the innate host defense of epithelial surfaces. Human beta defensin 1 (hBD-1) has recently been shown to be expressed in airway epithelial cells and so has been implicated as a primary component of antibacterial activity in human lung. We attempted to purify these molecules from bronchoalveolar lavage fluid (BALF). Extraction of BALF on SepPak C-18 cartridges, followed by continuous acid-urea polyacrylamide gel electrophoresis and reverse-phase high-performance liquid chromatography yielded one fraction with antibacterial activity associated with factors of < 6.5 kD. N-terminal amino acid sequencing identified these peptides as human neutrophil defensins (HD) 1 through 3. No hBD-1 was detected. Together with lysozyme, it appears that HD-1 through -3 are the most prominent antimicrobial factors in BALF. The contribution of epithelial defensins such as hBD-1 to antibacterial defense of human airway in vivo remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730862     DOI: 10.1165/ajrcmb.19.3.3384

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  10 in total

Review 1.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

Authors:  S Elahi; R Brownlie; J Korzeniowski; R Buchanan; B O'Connor; M S Peppler; S A Halperin; S F Lee; L A Babiuk; V Gerdts
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.

Authors:  Marissa H Braff; Amanda L Jones; Shawn J Skerrett; Craig E Rubens
Journal:  J Infect Dis       Date:  2007-03-15       Impact factor: 5.226

5.  ADP ribosylation of human neutrophil peptide-1 regulates its biological properties.

Authors:  Gregorino Paone; Akihiro Wada; Linda A Stevens; Abul Matin; Toshiya Hirayama; Rodney L Levine; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

6.  High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions.

Authors:  Kong T Chong; Liangbin Xiang; Xiaohong Wang; Eunjoo L Jun; Long-Fu Xi; John M Schweinfurth
Journal:  Virol J       Date:  2006-09-08       Impact factor: 4.099

7.  Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid.

Authors:  Abdul G Lone; Vincent Deslandes; John H E Nash; Mario Jacques; Janet I Macinnes
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

8.  Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.

Authors:  Katie L Propst-Graham; Laurel C Preheim; Elizabeth A Vander Top; Mary U Snitily; Martha J Gentry-Nielsen
Journal:  BMC Microbiol       Date:  2007-10-23       Impact factor: 3.605

Review 9.  Cationic host defence peptides: potential as antiviral therapeutics.

Authors:  Emily Gwyer Findlay; Silke M Currie; Donald J Davidson
Journal:  BioDrugs       Date:  2013-10       Impact factor: 5.807

Review 10.  Optical and dielectric sensors based on antimicrobial peptides for microorganism diagnosis.

Authors:  Rafael R Silva; Karen Y P S Avelino; Kalline L Ribeiro; Octavio L Franco; Maria D L Oliveira; Cesar A S Andrade
Journal:  Front Microbiol       Date:  2014-08-20       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.